Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center — Philadelphia, Pennsylvania

Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: BioInvent International AB.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center?

Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center conducted?

Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center accredited by Crixeo Health?

Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perelman School of Medicine/Hospital of the Univ. of Pennsylvania/Abramson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.